This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignee: Springworks Therapeutics, Inc.. Active years: 2021-2025.
Company Filing History:
Years Active: 2021-2025
Title: Yonghong Gan: Innovator in Pharmaceutical Chemistry
Introduction
Yonghong Gan is a notable inventor based in Simpsonville, SC (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for cancer treatment. With a total of 4 patents to her name, her work continues to impact the medical community.
Latest Patents
Yonghong Gan's latest patents include the crystalline solids of MEK inhibitor N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide. This patent discloses various aspects, including:
a) Crystalline forms of N—((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide.
b) Pharmaceutical compositions that comprise one or more crystalline forms of this compound, along with pharmaceutically acceptable carriers.
c) Methods for treating tumors, cancers, or Rasopathy disorders by administering these crystalline forms to subjects in need.
Career Highlights
Yonghong Gan is currently associated with Springworks Therapeutics, Inc., where she continues her research and development efforts. Her work is pivotal in advancing therapeutic options for patients suffering from various conditions.
Collaborations
Some of her notable coworkers include Peter Gregory Varlashkin and Ricky Wayne Couch. Their collaborative efforts contribute to the innovative environment at Springworks Therapeutics, Inc.
Conclusion
Yonghong Gan's contributions to pharmaceutical chemistry and her innovative patents highlight her role as a leading inventor in her field. Her work not only advances scientific knowledge but also offers hope for effective treatments in oncology.